Safety Rates Drug Report: DOXORUBICIN HYDROCHLORIDE. Graft versus host disease adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: DOXORUBICIN HYDROCHLORIDE. Injury: Graft versus host disease Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
127839421	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127840301	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127844431	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127844561	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867101	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867241	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127867721	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160927	CN
127881271	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160928	CN
127882451	DOXORUBICIN HYDROCHLORIDE.	Graft versus host disease	AVENTIS	0.00		0	20160928	CN

|< 1/2 << Previous Page Page 1

Total Records: 9 Number of Pages: 1

Execution Time: 0.013175964355469 seconds (ucode:5007609). Developed by: James D. Barger